Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment
2016 · Nature Communications · 261 citations
https://doi.org/10.1038/ncomms13710
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3
Papers
264
Citations
1
h-index
1
i10-index
Jong Seok Kang is an academic researcher from Io Therapeutics (United States). The author has contributed to research in topics: Microbial metabolism and enzyme function & Atherosclerosis and Cardiovascular Diseases & Lung Cancer Diagnosis and Treatment. The author has an h-index of 1, co-authored 3 publications.
Click to start Chat